rhabdomyolysis glp 1 Metabolic Flux Adaptations During GLP-1 Receptor Agonist Therapy: Redox Implications Frontiers | GLP-1 Receptor Agonists

Overweight and obesity Since ghrelin may contribute to food seeking and, perhaps, overindulgence during eating, it has received much attention concerning potential association with overweight and obesity

(2023, October 18)

They lower blood sugar and help you lose weight

These medications are indicated for adults with a BMI 30 kg/m (obesity) or 27 kg/m (overweight) with at least one weight-related comorbidity

This is important context when managing expectations of results from taking GLP-1s as well as addressing the internalized weight bias that many of us hold after marinating in diet and weight-biased medical culture